217 related articles for article (PubMed ID: 32026156)
1. Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research.
Hu P; Bai J; Liu M; Xue J; Chen T; Li R; Kuai X; Zhao H; Li X; Tian Y; Sun W; Xiong Y; Tang Q
Gastric Cancer; 2020 Jul; 23(4):591-599. PubMed ID: 32026156
[TBL] [Abstract][Full Text] [Related]
2. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
[TBL] [Abstract][Full Text] [Related]
3. Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system.
Zhang R; Guo Y; Wang Y; Hu L; Fang C; Yang Y; Yang X; Chen L; Chen J; Wang W; Sun X
Cancer Med; 2023 Mar; 12(6):6623-6636. PubMed ID: 36394081
[TBL] [Abstract][Full Text] [Related]
4. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
[TBL] [Abstract][Full Text] [Related]
5. A novel nomogram and risk stratification system predicting the cancer-specific survival of patients with gastric neuroendocrine carcinoma: a study based on SEER database and external validation.
Song X; Xie Y; Lou Y
BMC Gastroenterol; 2023 Jul; 23(1):238. PubMed ID: 37452300
[TBL] [Abstract][Full Text] [Related]
6. Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis.
Li J; Lin Y; Wang Y; Lin H; Lin F; Zhuang Q; Lin X; Wu J
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32253246
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and genetic characteristics of gastric neuroendocrine tumour (NET) G3 and comparisons with neuroendocrine carcinoma and NET G2.
Chen S; Sun L; Chen H; Li J; Lu C; Yang Y; Sun Y
Histopathology; 2023 Nov; 83(5):700-711. PubMed ID: 37403531
[TBL] [Abstract][Full Text] [Related]
8. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
[TBL] [Abstract][Full Text] [Related]
9. The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma.
Xu B; Chu Y; Hu Q; Song Q
Technol Cancer Res Treat; 2021; 20():15330338211055340. PubMed ID: 34806493
[TBL] [Abstract][Full Text] [Related]
10. [Establishment and validation of a nomogram to predict overall survival of patients with gastric neuroendocrine neoplasms].
Wang YL; Guo Y; Zhang RH; Chen LH; Yang YJ; Wang W; Chen J; Zhou ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):883-888. PubMed ID: 34674463
[No Abstract] [Full Text] [Related]
11. Comparison of nomogram for Primary Nonfunctional Pancreatic Neuroendocrine Tumors based on the 7th vs 8th edition of the AJCC cancer staging manual.
Heng X; Chen B; Zhao K; Li J; Wu W; Peng Y; Zhong R
PLoS One; 2023; 18(4):e0284930. PubMed ID: 37093837
[TBL] [Abstract][Full Text] [Related]
12. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study.
Cai JS; Chen HY; Lu YF; Yu RS
Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701
[No Abstract] [Full Text] [Related]
13. Modified AJCC staging of gastric neuroendocrine carcinoma based on T staging can improve the capacity of prognosis assessment.
Xie JW; Li P; Wang JB; Lin JX; Lu J; Chen QY; Yang YH; Kang DY; Zheng CH; Huang CM
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2391-2397. PubMed ID: 30209612
[TBL] [Abstract][Full Text] [Related]
14. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z
Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms.
Xu R; Zhou B; Hu P; Xue B; Gu D; Li X; Tang Q
World J Surg Oncol; 2021 Aug; 19(1):233. PubMed ID: 34364382
[TBL] [Abstract][Full Text] [Related]
16. De-escalating chemotherapy for stage I-II gastric neuroendocrine carcinoma? A real-world competing risk analysis.
Du D; Xie Y; Li X; Ni Z; Shi J; Huang H
World J Surg Oncol; 2023 May; 21(1):142. PubMed ID: 37149679
[TBL] [Abstract][Full Text] [Related]
17. Development and external validation of a prognostic nomogram for gastric cancer using the national cancer registry.
Liu J; Geng Q; Liu Z; Chen S; Guo J; Kong P; Chen Y; Li W; Zhou Z; Sun X; Zhan Y; Xu D
Oncotarget; 2016 Jun; 7(24):35853-35864. PubMed ID: 27016409
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nomogram to individually predict survival of young patients with nonmetastatic gastric cancer: A retrospective cohort study.
Wu C; Wang N; Zhou H; Wang T; Zhao D
Saudi J Gastroenterol; 2019; 25(4):236-244. PubMed ID: 30719999
[TBL] [Abstract][Full Text] [Related]
20. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
